Blood and Immunity Practice Questions

Q: Arrange the following clotting factors in sequence that they follow in the coagulation cascade: 1. Factor XIII, 2. Factor XII, 3. Factor X, 4. Factor V, 5. Factor IX?

2-5-3-4-1. ### Explanation The coagulation cascade is divided into the **Intrinsic**, **Extrinsic**, and **Common pathways**. To solve this sequence, one must trace the flow from the initiation of the intrinsic pathway to the final stabilization of the fibrin clot. 1. **Factor XII (Hageman factor):** Initiates the Intrinsic pathway upon contact with collagen or negatively charged surfaces. 2. **Factor IX (Christmas factor):** Activated by Factor XIa (within the intrinsic pathway). 3. **Factor X (Stuart-Prower factor):** The starting point of the **Common Pathway**. It is activated by the "Tenase complex" (IXa + VIIIa). 4. **Factor V (Proaccelerin):** Acts as a cofactor for Factor Xa to form the **Prothrombinase complex**, which converts Prothrombin to Thrombin. 5. **Factor XIII (Fibrin Stabilizing Factor):** The final step; it cross-links fibrin monomers into a stable polymer. Thus, the correct sequence is **2-5-3-4-1**. #### Analysis of Incorrect Options: * **Option A & D:** These place Factor X (3) before Factor IX (5). In the intrinsic pathway, IX must activate X. * **Option C:** This incorrectly starts with Factor XIII (1), which is the terminal factor of the cascade. #### NEET-PG High-Yield Pearls: * **Common Pathway mnemonic:** "Factors **10, 5, 2, 1**" (X, V, II, I). * **Vitamin K Dependent Factors:** II, VII, IX, and X (and Proteins C and S). * **Lab Correlation:** The **aPTT** measures the Intrinsic and Common pathways; **PT** measures the Extrinsic (Factor VII) and Common pathways. * **Factor XIII Deficiency:** Characterized by normal PT/aPTT but poor wound healing and delayed bleeding; diagnosed via the **Urea Solubility Test**.

Q: Which of the following substances inhibits platelet aggregation?

Bradykinin. **Explanation:** The regulation of platelet aggregation is a balance between pro-aggregatory (pro-thrombotic) and anti-aggregatory (anti-thrombotic) factors. **Why Bradykinin is correct:** Bradykinin is a potent vasodilator and an indirect inhibitor of platelet aggregation. It acts on the vascular endothelium to stimulate the release of **Nitric Oxide (NO)** and **Prostacyclin (PGI2)**. Both NO and PGI2 increase intracellular cyclic nucleotides (cGMP and cAMP, respectively) within platelets, which prevents their activation and aggregation. This mechanism ensures that the vascular lumen remains patent and prevents unnecessary clot formation. **Analysis of Incorrect Options:** * **A. Adenosine diphosphate (ADP):** Released from platelet dense granules, ADP is a powerful agonist that binds to P2Y1 and P2Y12 receptors, promoting platelet shape change and aggregation. * **B. Thromboxane A2 (TXA2):** A product of the cyclooxygenase (COX) pathway in platelets, TXA2 is a potent vasoconstrictor and platelet aggregator. Aspirin works by irreversibly inhibiting the COX-1 enzyme, thereby reducing TXA2 levels. * **C. Thrombin:** Known as the most potent platelet activator, thrombin converts fibrinogen to fibrin and activates platelets via Protease-Activated Receptors (PARs). **High-Yield NEET-PG Pearls:** * **Endogenous Inhibitors:** Prostacyclin (PGI2), Nitric Oxide, and Ecto-ADPase (CD39) are the primary physiological inhibitors of platelet aggregation. * **Platelet Receptors:** P2Y12 is the target for drugs like **Clopidogrel** and **Ticagrelor**. * **GP IIb/IIIa:** This is the "final common pathway" for platelet aggregation; its deficiency leads to **Glanzmann Thrombasthenia**.

Q: What is a characteristic feature of fetal red blood cells compared to adult red blood cells?

Resistant to alkali denaturation. ### Explanation **1. Why Option A is Correct: Resistance to Alkali Denaturation** The primary hemoglobin in fetal red blood cells (RBCs) is **Hemoglobin F (HbF)**, which consists of two alpha ($\alpha$) and two gamma ($\gamma$) chains. A key biochemical property of the $\gamma$-chains is their inherent resistance to denaturation by alkaline solutions (like KOH). In contrast, adult hemoglobin (HbA) is rapidly denatured by alkali. This difference forms the basis of the **Apt test**, used clinically to distinguish fetal blood from maternal blood in cases of neonatal gastrointestinal bleeding or vaginal bleeding during pregnancy. **2. Why Other Options are Incorrect:** * **Option B (Smaller in size):** Fetal RBCs are actually **larger** than adult RBCs. They are macrocytic, with a Mean Corpuscular Volume (MCV) often exceeding 110-120 fL at birth, compared to the adult average of 80-100 fL. * **Option C (Higher 2,3-DPG level):** Fetal RBCs do not have higher 2,3-DPG levels. More importantly, **HbF has a lower affinity for 2,3-DPG** than HbA. This allows HbF to maintain a higher affinity for oxygen, facilitating the transfer of oxygen from maternal blood to the fetus across the placenta. * **Option D (Contains more iron):** While the total iron stores in a neonate are high, the individual hemoglobin molecule contains the same four iron atoms (heme groups) as adult hemoglobin. **3. High-Yield Clinical Pearls for NEET-PG:** * **P50 Value:** The P50 (partial pressure of $O_2$ at which Hb is 50% saturated) is **lower** in fetal blood (~19 mmHg) than in adult blood (~27 mmHg), reflecting a left shift in the oxygen dissociation curve. * **Lifespan:** Fetal RBCs have a shorter lifespan (**80–90 days**) compared to adult RBCs (120 days). * **HbF Structure:** $\alpha_2\gamma_2$. The switch from $\gamma$ to $\beta$ chain synthesis begins before birth but is completed around 6 months of age.

Q: What is the first step in the initiation of primary hemostasis for clot formation?

Vasoconstriction. **Explanation:** Hemostasis is the physiological process that stops bleeding at the site of vascular injury. It occurs in three overlapping stages: **Vascular spasm (Vasoconstriction)**, **Primary Hemostasis** (Platelet plug formation), and **Secondary Hemostasis** (Coagulation cascade). **Why Vasoconstriction is the correct answer:** Immediately upon vascular injury, the smooth muscle in the vessel wall contracts. This is the **first and immediate response**. It is triggered by direct myogenic spasm, local autacoid factors (like Endothelin-1 released from damaged endothelium), and nervous system reflexes. The primary goal is to reduce blood flow to the injured area, minimizing blood loss and allowing pro-coagulant factors and platelets to accumulate at the site. **Analysis of Incorrect Options:** * **Platelet Adhesion:** This is the second step of primary hemostasis. It occurs only after vasoconstriction, when platelets bind to exposed subendothelial collagen via von Willebrand Factor (vWF). * **Fibrin Deposition:** This is the end-product of **Secondary Hemostasis** (the coagulation cascade). It stabilizes the initial platelet plug into a definitive clot. * **Thrombosis:** This is a pathological state where a clot forms within an intact blood vessel, rather than a physiological step in hemostasis. **NEET-PG High-Yield Pearls:** * **Sequence of Primary Hemostasis:** Vasoconstriction → Platelet Adhesion (GpIb-vWF) → Platelet Activation/Degranulation (ADP, TXA2) → Platelet Aggregation (GpIIb/IIIa). * **Potent Vasoconstrictor:** Endothelin-1 is the most potent endogenous vasoconstrictor released during vascular injury. * **Platelet Plug vs. Clot:** Primary hemostasis results in a "white thrombus" (unstable), while secondary hemostasis results in a "red thrombus" (stable fibrin mesh).

Q: Lysozyme is present in which of the following?

Saliva. **Explanation:** Lysozyme (also known as muramidase) is a critical enzyme of the **innate immune system**. It functions by hydrolyzing the β-1,4 glycosidic bonds between N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) in the peptidoglycan layer of bacterial cell walls, primarily targeting Gram-positive bacteria. While the question identifies **Saliva (Option A)** as the correct answer, it is important to note that this is a "single best response" scenario. Lysozyme is a ubiquitous enzyme found in almost all body secretions. * **Saliva (A):** It contains lysozyme, secretory IgA, and lactoferrin, which together provide the first line of defense against oral pathogens. * **Human Milk (B):** Lysozyme is present in high concentrations in breast milk (especially colostrum) and remains stable in the infant's gut to provide passive immunity. * **Tears (C):** The lacrimal glands secrete high amounts of lysozyme to protect the cornea and conjunctiva from infection. * **Mucus (D):** Respiratory and gastrointestinal mucus contain lysozyme to trap and degrade inhaled or ingested pathogens. **Note on Question Quality:** In many competitive exams like NEET-PG, if a question asks "where is it present" and all options are technically correct, the examiner may be looking for the most "classic" or "abundant" source, or the question may be flawed. However, historically, saliva and tears are the most frequently tested sources. **Clinical Pearls for NEET-PG:** 1. **Source:** Lysozyme is primarily synthesized by **neutrophils, monocytes, and macrophages**. 2. **Marker:** Elevated serum lysozyme levels are a diagnostic marker for **Sarcoidosis** and certain leukemias (specifically **AML-M4 and M5**). 3. **Paneth Cells:** In the small intestine, Paneth cells secrete large amounts of lysozyme to maintain mucosal immunity.

Q: In fetal life, which organs are primarily responsible for the production of red blood cells?

Prenatal life. ### Explanation The production of red blood cells (erythropoiesis) undergoes a series of transitions in location during human development. The question focuses on the primary site of production during **fetal life**, which corresponds to the **prenatal period**. **1. Why "Prenatal life" is correct:** During fetal development, erythropoiesis occurs in three distinct stages: * **Mesoblastic Stage (Weeks 3–8):** Occurs in the **yolk sac**. * **Hepatic Stage (Month 2 – Birth):** The **liver** becomes the primary site, with the spleen also contributing. * **Myeloid Stage (Month 5 onwards):** The **bone marrow** begins production and becomes the dominant site by the time of birth. Since all these stages occur before birth, "Prenatal life" is the accurate timeframe for these specific organ involvements. **2. Why the other options are incorrect:** * **First year of life & Up to five years:** After birth, the liver and spleen cease erythropoiesis. The **red bone marrow** of virtually all bones (long and flat) takes over. * **Lifelong:** While erythropoiesis is lifelong, the *organs* responsible change. In adults (after age 20), production is restricted to the **membranous/flat bones** (vertebrae, sternum, ribs, ilia) as the shaft of long bones undergoes fatty replacement (yellow marrow). **3. High-Yield Clinical Pearls for NEET-PG:** * **Order of sites:** Yolk sac → Liver (dominant) → Spleen → Bone Marrow. * **Extramedullary Erythropoiesis:** In certain pathological states (e.g., Thalassemia, Myelofibrosis), the liver and spleen can resume RBC production in adults. * **Hormonal Control:** Fetal erythropoiesis is initially independent of erythropoietin but later becomes dependent on it (produced primarily by the fetal liver, then the kidneys).

Q: Which of the following cells become tissue macrophages?

Monocytes. **Explanation:** **Monocytes** are the largest type of white blood cells and are considered immature cells while circulating in the bloodstream. They typically circulate for about 10–20 hours before migrating through the capillary walls into various tissues. Once they enter the tissues, they undergo significant enlargement and structural changes (increasing their lysosomal content and phagocytic capacity) to become **Tissue Macrophages**. This transition is part of the **Mononuclear Phagocyte System** (formerly known as the Reticuloendothelial System). **Why the other options are incorrect:** * **Neutrophils (A):** These are "first responders" to acute inflammation. While they are highly phagocytic, they are short-lived "professional" killers that die after phagocytosis (forming pus) and do not transform into macrophages. * **Eosinophils (B):** These are primarily involved in combating parasitic infections and mediating allergic responses. They do not differentiate into macrophages. * **Lymphocytes (D):** These are the primary cells of the adaptive immune system (B-cells and T-cells). They differentiate into plasma cells or effector T-cells, not macrophages. **High-Yield Clinical Pearls for NEET-PG:** * **Tissue-Specific Names:** Macrophages have specific names depending on their location: * **Liver:** Kupffer cells * **Lungs:** Alveolar macrophages (Dust cells) * **CNS:** Microglia * **Skin:** Langerhans cells * **Bone:** Osteoclasts * **Kidney:** Mesangial cells * **Function:** Macrophages act as **Antigen-Presenting Cells (APCs)**, linking the innate and adaptive immune systems by presenting processed antigens to T-lymphocytes via MHC II molecules.

Question 1

Which of the following factors does NOT affect the affinity of hemoglobin for oxygen?

Accepted Answer

PCO2

Answer

pH

Answer

Temperature

Answer

2,3-DPG

Question 2

Arrange the following clotting factors in sequence that they follow in the coagulation cascade: 1. Factor XIII, 2. Factor XII, 3. Factor X, 4. Factor V, 5. Factor IX?

Accepted Answer

2-5-3-4-1

Answer

2-3-4-1-5

Answer

1-2-5-3-4

Answer

2-3-5-4-1

Question 3

Which of the following substances inhibits platelet aggregation?

Accepted Answer

Bradykinin

Answer

Adenosine diphosphate (ADP)

Answer

Thromboxane A2

Answer

Thrombin

Question 4

What is a characteristic feature of fetal red blood cells compared to adult red blood cells?

Accepted Answer

Resistant to alkali denaturation

Answer

Smaller in size

Answer

Higher 2,3-DPG level

Answer

Contains more iron

Question 5

What is the first step in the initiation of primary hemostasis for clot formation?

Accepted Answer

Vasoconstriction

Answer

Fibrin deposition

Answer

Platelet adhesion

Answer

Thrombosis

Question 6

Lysozyme is present in which of the following?

Accepted Answer

Saliva

Answer

Human milk

Answer

Tears

Answer

Mucus

Question 7

In fetal life, which organs are primarily responsible for the production of red blood cells?

Accepted Answer

Prenatal life

Answer

First year of life

Answer

Up to five years of life

Answer

Lifelong

Question 8

Which of the following cells become tissue macrophages?

Accepted Answer

Monocytes

Answer

Neutrophils

Answer

Eosinophils

Answer

Lymphocytes

Question 9

A baby's blood group is determined as O Rh negative. Which of the following blood groups would neither the mother nor the father have?

Accepted Answer

AB, Rh Negative

Answer

A, Rh Positive

Answer

B, Rh Positive

Answer

O, Rh Positive

Question 10

The Schilling test is used to diagnose which condition?

Accepted Answer

Vitamin B12 deficiency

Answer

Folic acid deficiency

Answer

Vitamin B6 deficiency

Answer

Vitamin D deficiency

Blood and Immunity — MCQs

Blood and Immunity — MCQs

On this page

Practice by Chapter

Want unlimited practice?